tiprankstipranks
Advertisement
Advertisement

PLRX Stock Latest News

Pliant announces presentation of updated data from Phase 1 trial of PLN-101095
The FlyPliant announces presentation of updated data from Phase 1 trial of PLN-101095
11d ago
PLRX
Pliant Therapeutics Announces Board Retirements and Option Repricing
PremiumCompany Announcements
Pliant Therapeutics Announces Board Retirements and Option Repricing
12d ago
8K
PLRX
Pliant Therapeutics Launches New $50 Million ATM Program
PremiumCompany Announcements
Pliant Therapeutics Launches New $50 Million ATM Program
1M ago
8K
PLRX
Pliant Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Pliant Therapeutics files $300M mixed securities shelf
1M ago
PLRX
Pliant Therapeutics price target lowered to $3 from $4 at Canaccord
PremiumThe Fly
Pliant Therapeutics price target lowered to $3 from $4 at Canaccord
2M ago
PLRX
How Shareholder Activism Could Disrupt Pliant Therapeutics’ Strategy, Costs, and Stock Performance
PremiumCompany AnnouncementsHow Shareholder Activism Could Disrupt Pliant Therapeutics’ Strategy, Costs, and Stock Performance
2M ago
PLRX
Pliant Therapeutics price target lowered to $3 from $4 at Piper Sandler
Premium
The Fly
Pliant Therapeutics price target lowered to $3 from $4 at Piper Sandler
2M ago
PLRX
Pliant Therapeutics reports Q4 EPS (38c), consensus (38c)
Premium
The Fly
Pliant Therapeutics reports Q4 EPS (38c), consensus (38c)
2M ago
PLRX
Pliant Therapeutics Extends Stockholder Rights Agreement Expiration
PremiumCompany Announcements
Pliant Therapeutics Extends Stockholder Rights Agreement Expiration
2M ago
8K
PLRX
PLRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PLRX Earnings this Week: How Will it Perform?
2M ago
PLRX
Pliant Therapeutics Appoints Minnie Kuo as COO
PremiumCompany Announcements
Pliant Therapeutics Appoints Minnie Kuo as COO
4M ago
8K
PLRX
Pliant Therapeutics Announces Departure of Chief Medical Officer
PremiumCompany Announcements
Pliant Therapeutics Announces Departure of Chief Medical Officer
5M ago
8K
PLRX
Pliant Therapeutics announces interim data from PLN-101095
PremiumThe FlyPliant Therapeutics announces interim data from PLN-101095
5M ago
PLRX
Pliant Therapeutics Reports Improved Q3 2025 Results
Premium
Company Announcements
Pliant Therapeutics Reports Improved Q3 2025 Results
6M ago
PLRX
Pliant Therapeutics reports Q3 EPS (43c), consensus (52c)
Premium
The Fly
Pliant Therapeutics reports Q3 EPS (43c), consensus (52c)
6M ago
PLRX
Pliant Therapeutics Announces CBO Hans Hull’s Resignation
PremiumCompany Announcements
Pliant Therapeutics Announces CBO Hans Hull’s Resignation
6M ago
8K
PLRX
Pliant Therapeutics Settles Loan with Oxford Finance
PremiumCompany Announcements
Pliant Therapeutics Settles Loan with Oxford Finance
6M ago
8K
PLRX
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
7M ago
MU
AMD
Align downgraded, NetEase upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Align downgraded, NetEase upgraded: Wall Street’s top analyst calls
7M ago
ABT
MOS
Pliant Therapeutics downgraded to Underweight from Neutral at JPMorgan
PremiumThe FlyPliant Therapeutics downgraded to Underweight from Neutral at JPMorgan
7M ago
PLRX
Pliant Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Pliant Therapeutics Reports Q2 2025 Financial Results
9M ago
PLRX
Pliant Therapeutics price target raised to $1.70 from $1.50 at Citi
Premium
The Fly
Pliant Therapeutics price target raised to $1.70 from $1.50 at Citi
9M ago
PLRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >